Calcium signaling plays a role in synaptic regulation of dendritic structure, usually on the time scale of hours or days. Here we use immunocytochemistry to examine changes in expression of plasma membrane calcium ATPase type 2 (PMCA2), a high-affinity calcium efflux protein, in the chick nucleus laminaris (NL) following manipulations of synaptic inputs. Dendrites of NL neurons segregate into dorsal and ventral domains, receiving excitatory input from the ipsilateral and contralateral ears, respectively, via nucleus magnocellularis (NM). Deprivation of the contralateral projection from NM to NL leads to rapid retraction of ventral, but not the dorsal, dendrites of NL neurons. Immunocytochemistry revealed symmetric distribution of PMCA2 in two neuropil regions of normally innervated NL. Electron microscopy confirmed that PMCA2 localizes in both NM terminals and NL dendrites. As early as 30 minutes after transection of the contralateral projection from NM to NL or unilateral cochlea removal, significant decreases in PMCA2 immunoreactivity were seen in the deprived neuropil of NL compared with the other neuropil that continued to receive normal input. The rapid decrease correlated with reductions in the immunoreactivity for microtubule-associated protein 2, which affects cytoskeleton stabilization. These results suggest that PMCA2 is regulated independently in ventral and dorsal NL dendrites and/or their inputs from NM in a way that is correlated with presynaptic activity. This provides a potential mechanism by which deprivation can change calcium transport that, in turn, may be important for rapid, compartmentspecific dendritic remodeling. 
MATERIALS AND METHODS
White leghorn chick hatchlings (Gallus domesticus) 4 -11 days of age were used. In addition, 6-week-old CBA/CaJ deafwaddler (dfw 2J ) mice (Street et al., 1998) and their wildtype littermates were used for comparison in Western blot analysis. All procedures were approved by the University of Washington Institutional Animal Care and Use Committee and conformed to NIH guidelines. All efforts were made to minimize pain or discomfort of the animals and to minimize the number of the animals used.
Transection of the crossed dorsal cochlear tract (XDCT)
Animals were anesthetized with a mixture of 40 mg/kg ketamine and 12 mg/kg xylazine. The animals were placed in a head holder, and surgery was conducted by using the method of Deitch and Rubel (1984) . Briefly, the neck muscles were resected to expose the dura covering the cerebellomedullary cistern. An ophthalmic knife was inserted through the dura and the fourth ventricle and into the brainstem to transect the XDCT at the midline. The wound was packed with gelfoam and sealed with a tissue adhesive, LiquiVet (Oasis Medical, Mettawa, IL). The location and extent of the transection were examined after further tissue processing (see below). In total, 23 animals received a complete transection of XDCT. Four were allowed to survive for 0 hours, six for 0.5 hours, five for 3 hours, three for 6 hours, and five for 14 hours. The 0-hour survival time refers to an immediate perfusion (less than 5 minutes) after the surgery. These cases served as a second set of controls, in addition to unoperated animals (n ‫؍‬ 6). In addition, five animals received midline incisions that were either caudal or rostral to the XDCT, without damaging NM neurons or their axons, and survived for 0.5-12 hours. These cases served as sham-operated controls.
Cochlea removal
The procedure described by Born and Rubel (1985) was used. Animals were anesthetized as described above. A small incision was made to widen the external auditory meatus of the ear, and the tympanic membrane and columella were removed to expose the oval window. The basilar papilla, including the lagena macula, was removed via the oval window using fine forceps, floated on water, and examined with a surgical microscope to verify complete removal. Only animals with a complete removal of the basilar papilla, including the lagena, were used for further tissue processing and data analysis. The cochlear duct was packed with a small piece of gelfoam. The incision was sealed with LiquiVet adhesive. This procedure results in complete removal of the basilar papilla but spares the ganglion cells, which subsequently die over the next few weeks (Born and Rubel, 1985) . In total, 38 animals received a unilateral cochlea removal (right ear). Four were allowed to survive for 0 hours, four for 0.5 hours, 12 for 3 hours, nine for 6 hours, and nine for 14 hours. In addition, five animals received bilateral cochlea removal and survived for 3 hours.
Immunocytochemistry
The animals were anesthetized and transcardially perfused with 0.9% saline, followed by 4% paraformaldehyde in 0.1 M phosphate buffer. The brains were removed from the skull and postfixed overnight in the same fixative. Completeness of the XDCT transection was verified under a microscope after removal of the cerebellum, and incomplete cases were discarded. The brains were then either transferred to 30% sucrose in phosphate-buffered saline (PBS; pH 7.4) until they sank and cut coronally at 30 m on a freezing sliding microtome or washed in PBS and cut coronally at 40 m on a vibratome. Sections were collected in PBS into four alternate series, each containing eight or nine sections through NL. Alternate sets of one in four sections were stained for Nissl substance or immunocytochemically for PMCA2, SNAP-25, and MAP2 by peroxidase or fluorescent immunocytochemical methods. Briefly, free-floating sections were incubated with primary antibody solutions diluted 1:1,000 in PBS with 0.3% Triton X-100 overnight at 4°C, followed by biotinylated antiIgG antibodies (1:200; Vector Laboratories, Burlingame, CA) or AlexaFluor secondary antibodies (1:200; Molecular Probes, Eugene, OR) for 2 hours at room temperature.
Western blotting
Western blot immunoassay was conducted to confirm that the anti-PMCA2 antibody used in the present study recognizes similar proteins in chicks compared with mammals. Protein samples were harvested from the NL/NM and the surrounding region in the dorsocaudal brainstem of chicks and the whole brain of mice. An additional whole-brain sample from the dfw 2J homozygous mutant mouse that is known to lack PMCA2 immunoreactivity (McCullough and Tempel, 2004) was used as a negative control. All samples were homogenized in lysis buffer (20 mM NaF, 1 mM Na vanadate, 0.5% Triton X-100, 0.1% SDS, 10 mM Tris, and 150 mM NaCl) with protease inhibitor cocktail (catalog No. P8340; Sigma). Protein concentrations were determined by using BCA Protein Assay (Pierce, Rockford, IL). Each sample (5 g or 12.5 g protein) was boiled for 5 minutes to denature protein and loaded onto a 4 -20% SDS-polyacrylamide gel (Bio-Rad, Hercules, CA). The gel was run for 100 minutes at 100 V. Protein was then electroblotted to a PVDF membrane (Bio-Rad). Membranes were blocked in 5% nonfat milk in TBS (10 mM Tris and 150 mM NaCl) and probed with the PMCA2 antibody (1:1,000). Horseradish peroxidase (HRP)-conjugated secondary antibodies (1:3,000; Bio-Rad) were used for detection with enhanced chemiluminescent reagents (ECL; Amersham, Little Chalfont, Buckinghamshire, England). An antibody against ␤-actin (Abcam Inc, Cambridge, MA) was used as a protein loading control.
Transmission electron microscopy
Two chicks were anesthetized and transcardially perfused with 0.9% saline followed by 2% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M acetate buffer (pH 6.0) for 5 minutes and then by the same concentration of aldehydes in 0.06 M borate buffer (pH 8.5) for 20 minutes (Berod et al., 1981; Bodor et al., 2005 ). Brains were dissected and then immersed in the latter fixative for 40 minutes. Brains were washed in 0.1 M phosphate buffer (PB), and coronal sections of the brainstem containing NM and NL were cut on a vibratome at 50 m. Sections were cryoprotected in 10%, 20%, and 30% sucrose in PB prior to three freeze-thaw cycles in liquid nitrogen. Sections were treated with 0.5% sodium borohydride for 15 minutes and returned to 0.1 M PB.
Blocking was performed in a solution containing 5% normal goat serum, 0.8% BSA, 0.1% cold water fish skin gelatin, 0.05% sodium azide in 50 mM Tris buffer (pH 7.4) for 1 hour. This solution was replaced with a 1:1,000 dilution of rabbit anti-PMCA2 in the same buffer overnight at 4°C with gentle agitation. Several sections were maintained in the blocking buffer as a no-primary control. After washes, sections were incubated in a 1:50 dilution of goat anti-rabbit ultrasmall (0.6 nm) gold (No. 25101; EMS) for 2 hours. Additional washes were performed prior to incubation in a 1:10 dilution of Enhancement Conditioning Solution (No. 25830; EMS) and subsequent silver enhancement. After washes, the sections were treated with 1% OsO 4 for 2 minutes, followed by 0.5% OsO 4 for 20 minutes, both in 0.1 M PB. Sections were washed, dehydrated, and embedded in Eponate 12 resin (Ted Pella, Inc., Redding, CA) prior to obtaining ultrathin sections. After remounting of the vibratome sections on blank resin stubs, 100-nm ultrathin sections were made from the surface (1-2 m) of the immunoreacted sections. Ultrathin sections were mounted on 200-mesh, Athene thin bar grids (Ted Pella, Inc.), contrasted with uranyl acetate and lead citrate, and viewed in a JEOL 1200 EX transmission electron microscope.
Data analysis in NL
Both XDCT transection and unilateral cochlea removal compromise the excitatory activity to one dendritic domain of NL (referred to here as the deprived domain) and leave the afferent activity to another domain uncompromised (referred to here as the intact domain). The structure and function of the intact domain of NL are largely unchanged following the manipulations used here (Lippe et al., 1980; Rubel, 1984, 1989; Born et al., 1991) , so the change in the density of PMCA2 immunoreactivity in the deprived domain was estimated by the difference between two neuropil domains. This method was adopted to avoid potential inconsistencies caused by variations in immunostaining between cases (Lippe et al., 1980; Durham and Rubel, 1985; Born et al., 1991; Wang and Rubel, 2008) . In our preparations, the staining intensity of PMCA2 in the intact domain of NL neuropil was qualitatively similar before and after the manipulations (see Figs. 6, 9) . Thus, we assume that the differences of PMCA2 immunoreactivity between two neuropil domains were due largely to the changes in the deprived neuropil. However, the methods used in the current study could not determine the subcellular compartment(s) in which PMCA2 changes occurred in response to our manipulations. In addition, PMCA2 immunoreactivity within the cell body layer, which contains NL neuronal somata and laterally oriented, short dendritic branches (Smith, 1981) , was excluded from the analyses described below.
Two types of analyses were conducted to quantify relative differences between the dorsal and the ventral neuropil domains of NL with respect to PMCA2 immunoreactivity within the first 14 hours following the manipulations. First we measured and compared the average density of the immunostaining between the deprived and the intact domains in the same region of NL. At least three cases were chosen for this analysis from each survival time and manipulation group. A second type of analysis was conducted to evaluate the overall change in the density of PMCA2 staining as a function of dendritic position (proximal vs. distal) from the NL neuron soma. Representative sections with a PD value smaller than -20 were chosen for this analysis from the cases that survived 0.5-6 hours following XDCT transection. Each neuropil domain was divided into subzones from proximal (adjacent to the soma) to distal dendrites at intervals of 5 m. The PD between the deprived and the control domains was calculated between comparable subzones at the same distance from the same NL neuron somata.
Significance was determined by using one-way ANOVA followed by Tukey's multiple-comparisons test or two-way ANOVA followed by Bonferroni posttest, in the Prism v. 5 software package (GraphPad Software, Inc., San Diego, CA). P < 0.05 was considered statistically significant. All data are shown as mean ؎ 1 SD in the text and figures.
Data analysis in NM
In the group that received unilateral cochlea removal, changes in the density of PMCA2 immunostaining were quantified between the ipsilateral and the contralateral NM from individual tissue sections. For each case, three images were taken from each side of NM with a ؋20 air objective (NA 0.75) at a total magnification of ؋240. 
RESULTS

Western blotting
Distribution and localization of PMCA2 in the normal NL and NM
In chicks, NL neurons are arranged in a single layer, except in the most caudolateral region of the nucleus, where multiple layers of neurons are present. Dendrites of NL neurons are segregated into dorsal and ventral domains that are bordered by two glial-rich layers. Immunocytochemistry revealed that PMCA2 is expressed at high levels throughout the NL neuropil region and around cell bodies, where NM terminals form synapses with NL neurons. Symmetric distribution of PMCA2 in the dorsal and ventral neuropil of NL formed two dense bands separated by a lightly stained cell body layer where the immunoreactivity was found mostly around the somata (Fig.  2A,B,D,G) . The major immunoreactivity in the neuropil region overlapped with the immunoreactivity for MAP2, a neuronal somatodendritic marker (Fig. 2D-F) , and was confined between the two glial layers (Fig. 2G-I) . The average densities of PMCA2 immunoreactivity in the ventral and dorsal neuropil regions were not qualitatively different, and quantitative measurements did not reveal any statistically significant differences. Within NM, most neurons are adendritic or have only a single, short primary dendrite in P4 -P10 chicks (Conlee and Parks, 1983) . Immunoreactivity for PMCA2 was located perisomatically in NM neurons (Fig. 2C) . In addition, immunoreactivity was also observed surrounding a number of smaller nuclei in NL neuropil regions and the adjacent glial layers (inset of Fig. 2B ) as well as in NM (Fig. 2C) Fig. 3 ). However, cellular structures labeled with PMCA2 but lacking SNAP-25 were also widely detected (white arrowheads, Fig.  3 ). TEM observation confirmed that PMCA2 is localized in both pre-and postsynaptic compartments in the neuropil region of NL (Fig. 4) 
PMCA2 immunoreactivity in NL following XDCT transection
The XDCT contains the decussating NM axons that project to the ventral NL on both sides of the brain. A complete transection of XDCT at the midline eliminates the excitatory input to the ventral dendrites of NL neurons, while leaving the input to the dorsal dendrites intact (Fig. 5A,C) . After XDCT transection, the afferent terminals from NM on the ventral NL dendrites do not show significant atrophic changes at the electron microscopic level during the first 4 hours (Deitch and Rubel, 1989) .
The relative change in PMCA2 immunoreactivity in the deprived ventral neuropil compared with the intact dorsal neuropil exhibited a time-dependent pattern (Figs. 6, 7) . Immediately after the surgery (0 hours), no reliable difference in the density of staining was observed between the two neuropil domains (Fig. 6B) , and quantitative analyses supported this observation. The percentage difference (PD) of the staining density in the ventral neuropil compared with the dorsal neuropil (0.0 ؎ 8.5) was not significantly different from that of the unoperated control (-2.8 ؎ 1.3; Fig. 7A ). Thirty minutes later, however, the ventral neuropil exhibited notably lower density of PMCA2 immunoreactivity compared with the dorsal neuropil in all but one case (Fig. 6C) . The average PD across all six cases was -25.6 ؎ 23.9. At 3-14 hours following the transection, a relatively lower density of staining in the ventral neuropil was detected consistently with the average PD of -32.0 ؎ 3.9 at 3 hours, -26.9 ؎ 5.2 at 6 hours, and -23.7 ؎ 8.0 at 14 hours (Figs. 6D-F, 7A ). These PD values were significantly smaller than the unoperated controls at all four survival periods (Ps < 0.001).
Changes in the density of PMCA2 immunoreactivity in the ventral neuropil occurred symmetrically on both sides of the brain (Fig. 5C) . On each side, the change was detected throughout the rostrocaudal and lateromedial extent of the nucleus (Fig. 7B) . A two-way ANOVA (survival time by position) did not yield significant interaction between these two parameters, indicating the overall effect of the manipulation on the staining density does not vary with the position of the dendrites along the rostrocaudal axis of the nucleus. A slightly smaller mean of PD in the caudal NL than in the intermediate and rostral NL may be due to differential neuronal arrangements between the caudal and the other regions of NL. At any given location of the NL, the difference in the density of PMCA2 staining between the two neuropil domains was distributed throughout its proximal and distal extent (Fig. 8) . Each subzone of the ventral neuropil exhibited a dramatic decrease of staining in comparison with the analogous subzone in the 
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dorsal neuropil, although the PDs calculated from individual subzones varied across cases. In the sham-operated subjects that received midline incisions that were either caudal or rostral to the XDCT without damaging NM neurons or their axons, there was no reliable difference in the density of PMCA2 immunostaining between the dorsal and the ventral NL neuropil domains at any survival times (Fig. 7A,B) . The PDs (-3.6 ؎ 2.1) were not significantly different from those of the unoperated control subjects, indicating that the observed decreases in PMCA2 immunoreactivity in the ventral NL neuropil following transection of XDCT were not caused by lesion-related cytotoxic events.
PMCA2 immunoreactivity in NL following unilateral cochlea removal
The eighth nerve is the only excitatory input to NM neurons. Unilateral cochlea removal eliminates excitatory action potentials in both the eighth nerve and the ipsilateral NM and thus eliminates spike generation in the excitatory axons to the dorsal dendrites of the ipsilateral NL and the ventral dendrites of the contralateral NL ( Fig. 5B; Born et al., 1991) . Cochlear ganglion cells and NM neurons begin to die about 12-24 hours after cochlea removal, and by 48 hours about 30% NM neurons have degenerated (Rubel et al., 1990) .
Immediately after the unilateral cochlea removal (0 hours), the density of PMCA2 staining showed no reliable qualitative or quantitative differences between the dorsal and the ventral neuropil domains on either side of the brain (Fig. 7A) . The PD values were not significantly different from those of the unoperated control group on the ipsilateral side (-2.1 ؎ 9.7) or on the contralateral side (-6.1 ؎ 9.7). On the other hand, from 30 minutes to 14 hours following cochlea removal, the ventral neuropil contralateral to the cochlea removal exhibited a readily apparent and statistically significant decrease in PMCA2 immunoreactivity compared with the adjacent dorsal neuropil of the same neurons (Figs. 7A, 9A,C,E) , with a time course comparable to that following XDCT transection. The relative PD in the staining density was -17.6 ؎ 15.7 at 30 minutes, -31.1 ؎ 10.2 at 3 hours, -19.7 ؎ 5.8 at 6 hours, and -26.0 ؎ 9.1 at 14 hours. These PD values were all significantly less than those of the unoperated control group (Ps < 0.001).
Unexpectedly, changes in PMCA2 immunoreactivity in the dorsal neuropil of the ipsilateral NL appeared smaller and less reliable than in the ventral neuropil of the contralateral NL (Figs. 7A, 9B,D,F) . Qualitative examination of the tissue did not reveal a reliable difference in the staining density between the two neuropil domains of the ipsilateral NL until 3 hours after the manipulation. Quantification and statistical analysis across all cases within individual survival groups revealed a significantly smaller PD value at 3 hours (-12.6 ؎ 8.2; P < 0.01) and 6 hours (-15.3 ؎ 10.8; P < 0.01), but not at 0.5 hours (-3.1 ؎ 12.9) or 14 hours (-4.5 ؎ 3.8), compared with the 
Low-magnification (A,B) and high-magnification (C-H) photomicrographs of sections doubly labeled with PMCA2 (green) and the presynaptic maker SNAP-25 (magenta) in NL (A,F-H) and NM (B-E). E and H are merged images of NM neuron soma and NL neuopil region, respectively. Arrows and arrowheads indicate the subcellular components with double labeling or with single labeling for PMCA2, respectively. Scale bars ‫؍‬ 50 m in B (applies to A,B); 5 m in E (applies to C-E); 7.5 m in H (applies to F-H).
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PMCA2 immunoreactivity in NL following bilateral cochlea removal
The asymmetry of the effect of unilateral cochlea removal on the deprived dorsal and ventral neuropil of NL provides a means to examine whether the elimination of activity in one neuropil domain or the loss of the balance of the activity between the two neuropil domains is responsible for the observed changes in PMCA2 immunoreactivity. If the balance of the activity is sufficient to maintain the PMCA2 immunoreactivity in NL neuropil, bilateral cochlea removal should produce no change in staining density in either domain and thus no difference between two domains. Otherwise, because of the differential effects of unilateral cochlea removal on the deprived dorsal and ventral neuropil, we should detect a difference of staining density between two neuropil domains following bilateral cochlea removal.
Five animals received bilateral cochlea removal and survived for 3 hours, the time point at which the most dramatic changes were found following a single operation of either XDCT transection or unilateral cochlea removal. For all five cases, the density of PMCA2 immunoreactivity in the ventral neuropil was significantly smaller than the dorsal neuropil (P < 0.001; Fig. 10 ). The PD of staining density between the ventral and the dorsal neuropil domains (-24.4 ؎ 3.4) was significantly smaller than that of the unoperated control group (P < 0.001). This difference may result, at least partially, from different levels of response of each neuropil domain to the deprivation of presynaptic activity. However, whether the breakdown of the balance of activity between two neuropil domains also contributed to the changes in PMCA2 immunoreactivity could not be determined by this comparison.
Correlation of changes in PMCA2 immunoreactivity with MAP2 immunoreactivity
To explore whether the changes in PMCA2 immunoreactivity are associated with structural changes of NL dendrites, 
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The Journal of Comparative Neurology 631 SYNAPTIC REGULATION OF PMCA2 changes in PMCA2 immunoreactivity were plotted as a function of changes in MAP2 immunoreactivity following unilateral cochlea removal (Fig. 11) . The average PD of PMCA2 immunoreactivity in the contralateral NL (-16.9 ؎ 7.7) was significantly greater than that in the ipsilateral NL (-4.2 ؎ 6.1), consistent with the quantification analyses described above, although the absolute values of the PDs measured from sections with fluorescent immunocytochemical staining (Fig. 11) are smaller than those measured from sections with peroxidase staining (Fig. 7) . On the other hand, the average PD of MAP2 immunoreactivity was not significantly different between the contralateral (-30.3 ؎ 9.9) and the ipsilateral (-35.2 ؎ 12.8) sides, consistent with our previous report (Wang and Rubel, 2008) . Although the PDs in immunoreactivity varied among cases, those with a larger change in PMCA2 immunoreactivity tended to have a larger change in MAP2 immunoreactivity. This correlation was evident on both contralateral (Fig. 11A) and ipsilateral (Fig. 11B) sides. Post hoc linear trend analysis reveals a highly significant trend toward increasing changes in MAP2 as a function of changes in PMCA2 (P < 0.001).
PMCA2 immunoreactivity in NM following
unilateral cochlea removal PMCA2 immunoreactivity in the deprived ipsilateral NM was examined following unilateral cochlea removal and compared with that in the intact contralateral NM. During the entire 14-hour observation period following the manipulation, no distinct difference between the ipsilateral and the contralateral NM was detected in either the staining pattern or the average density of the immunoreactivity (Fig. 12) . Almost every neuron in NM displayed a perisomatic staining of PMCA2 before and after the manipulation. One-way ANOVA followed by post hoc comparisons revealed no significant difference in the average density of staining between the two sides measured from the middle portion of the nucleus at all survival times. 
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DISCUSSION
In this study, we demonstrate that the calcium efflux protein PMCA2 is regulated independently and/or differentially in subcellular compartments of individual neurons in a way that is correlated with presynaptic activity. In the chick auditory brainstem, PMCA2 immunoreactivity is rapidly and differentially down-regulated in NL dendrites and/or presynaptic terminals from NM where presynaptic action potentials have been eliminated, but not in corresponding elements on the other side of the same neurons that are receiving inputs showing normal action potential rates. In addition, PMCA2 immunoreactivity in the somata of NM neurons does not appear to 
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One important caveat of this study is that we cannot determine with the present analyses whether the deprivationinduced changes in PMCA2 immunoreactivity are presynaptic or postsynaptic or both. Our results and other TEM localiza- ., 1990) . Second, after XDCT transection, a significant reduction of neurofilaments and microtubules was seen in the ventral NL dendrites by 4 hours, but, at that time and for several hours thereafter, no changes were noted in the ultrastructure of the NM synapses on these dendrites (Deitch and Rubel, 1989) . Third, PMCA2 immunoreactivity in the dorsal and ventral NL neuropil domains showed different sensitivities to the manipulations of presynaptic activity (the present study). These observations do not prove that the observed changes in PMCA2 immunoreactivity do not take place in presynaptic structures in NL neuropil. However, they certainly suggest that the most significant changes following our manipulations, particularly at the short intervals, are taking place in the dendrites.
Time course of PMCA2 changes in NL
Loss of PMCA2 immunoreactivity does not appear to be a direct consequence of accompanying reductions in the membrane surface of NL dendrites. A significant decrease of PMCA2 immunoreactivity by 18 -26% at 0.5 hours indicates a decrease in the density of the immunoreactivity on the dendritic surface. At this early time point, changes in the total dendritic branch length and area of NL neurons are not detectable (Deitch and Rubel, 1984; Sorensen and Rubel, 2006) . 
Synaptic regulation of PMCA2
The immediate loss of PMCA2 immunoreactivity is one of the earliest cellular processes in NL neuropil following deprivation of excitatory inputs, along with changes in 2-deoxyglucose uptake (Lippe et al., 1980) , and occurs well before detectable structural changes Rubel, 1984, 1989; Wang and Rubel, 2008) and metabolism alterations (Durham and Rubel, 1985) . The rapidity of changes in PMCA2 immunoreactivity, consistent with its occurrence throughout the neuropil domain, places major constraints on the cellular processes that might mediate these changes. Sham operations showed that these PMCA2 changes were not caused by lesion-related cytotoxic events to the surrounding tissue. Instead, decreases in PMCA2 immunoreactivity are likely to be activity dependent, insofar as both XDCT transection and cochlea removal cause an immediate cessation of action potentials of excitatory NM afferents to affected NL dendrites (Born et al., 1991) . Possible changes in presynaptically localized PMCA2 could be a direct consequence of changes in calcium influx through voltage-gated calcium channels. Dendritic PMCA2, on the other hand, may respond to the interruption of neurotransmission and concomitant cessation of glutamate release. Glutamate receptors that may regulate PMCA2 through a calcium-dependent mechanism include calcium-permeable AMPA and NMDA receptors and metabotropic glutamate receptors that mediate [Ca 2؉ ] i through their inhibition on voltage-gated calcium channels and release from intracellular calcium stores (Zirpel and Rubel, 1996; Lu and Rubel, 2005) .
In addition to glutamate receptors, activation of neurotrophin receptors may also regulate PMCA2 in NL dendrites. One unexpected observation in the current study is that changes in the density of PMCA2 immunoreactivity in deprived dorsal neuropil were significantly smaller than those in deprived ventral neuropil, indicating that PMCA2 immunoreactivity is regulated somewhat differentially in the two NL neuropil domains. These differential responses imply that other cellular pathways with varied expression and/or function between two domains may modulate the activity-dependent PMCA2 expression. Of most interest is the restricted distribution of the TrKB receptor in the ventral, but not the dorsal, NL dendrites 
PMCA2 in dendritic regulation
PMCA2 in presynaptic structures
PMCA2 regulation: cell-type specific
It is perhaps surprising that NM did not show a discernible change in PMCA2 immunoreactivity following cochlea removal, given the fact that cochlea removal deprives both NM and NL of excitatory afferent input (Born et al., 1991) . In addition, cochlea removal results in a rapid increase of [Ca 2؉ ] i in all deprived NM neurons that results in the death of approximately 30% of these neurons within 2 days (Born and Rubel, 1985; Zirpel et al., 1995; Zirpel and Rubel, 1996) . For a number of cell systems, PMCA has been suggested to be an important 
